{"gene":"PF3D7_1438400","run_date":"2026-09-08T14:19:07","timeline":{"discoveries":[{"year":2018,"finding":"MCA2 (PfMCA-2) is a cysteine protease that cleaves arginine/lysine-specific peptide substrates (z-GRR-AMC) but not caspase-specific substrates (Z-VAD-FMK, Z-DEVD-FMK substrates), and is inhibited by Z-FA-FMK but not general caspase inhibitors. MCA2 also cleaves the phylogenetically conserved protein Tudor staphylococcal nuclease (PfTSN) as a natural substrate.","method":"Enzymatic assay with fluorogenic peptide substrates; inhibitor profiling with Z-FA-FMK, aprotinin, E-64, Z-VAD-FMK, Z-DEVD-FMK; in vitro cleavage assay with PfTSN","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro enzymatic assay with substrate specificity profiling and inhibitor panel, single lab but multiple orthogonal methods","pmids":["29317266"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"MCA2 (PfMCA-2) is specifically expressed in schizont and gametocyte stages of P. falciparum. Treatment with Z-FA-FMK caused notable depletion of MCA2 expression in these stages and blocked parasite growth (IC50 2.7 µM), accompanied by phosphatidylserine externalization and DNA fragmentation indicative of apoptosis-like death.","method":"Western blot for stage-specific expression; drug treatment with Z-FA-FMK; parasite growth inhibition assay; flow cytometry for phosphatidylserine externalization and DNA fragmentation","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal readouts (expression, growth, apoptosis markers), single lab","pmids":["29317266"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2021,"finding":"Active-site mutagenesis of MCA2 (PfMCA-2) established that the catalytic dyad residues Cys157 and His205 are essential for enzymatic activity with the artificial substrate z-GRR-AMC. The residue Tyr224 is not required for activity with the artificial substrate but is required for binding and cleavage of the natural substrate PfTSN; Cys157 is also required for PfTSN interaction, indicating MCA2 cleaves PfTSN via a non-canonical binding mode using non-conserved residues.","method":"Site-directed mutagenesis of Cys157, His205, and Tyr224; in vitro and in vivo PfTSN cleavage assays; enzymatic assay with z-GRR-AMC","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — active-site mutagenesis combined with in vitro and in vivo substrate cleavage assays, single lab","pmids":["35670460"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"finding":"A specific small-molecule inhibitor (SS-5) inhibited MCA2 (PfMCA-2) activity and expression without inhibiting falcipains, plasmepsins, vivapain, human cathepsins B/D/L, or caspases-3/7, demonstrating selectivity. Inhibition of MCA2 by SS-5 led to persistent oxidative stress, mitochondrial potential depolarization, and intracellular Ca2+ accumulation, causing apoptosis-like parasite death in vitro (IC50 1 µM). SS-5 also inhibited P. berghei development in a murine model.","method":"Enzyme activity assays with selectivity panel; parasite growth inhibition (IC50); ROS measurement; mitochondrial membrane potential assay; Ca2+ accumulation assay; murine P. berghei in vivo model","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional assays with selective inhibitor, replicated in two Plasmodium species, single lab","pmids":["32202613"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium berghei","strain":""}]},{"year":2022,"finding":"Genetic knockout of MCA2 in P. berghei demonstrated that MCA2 is required for normal gametocyte formation, and for maintaining appropriate numbers of oocysts, ookinetes, and sporozoites; MCA2 knockout parasites also showed delayed hepatocyte invasion. Inhibitors C-532 and C-533 inhibited MCA2 activity, blocked in vitro parasite growth, and impaired transmission of P. falciparum and P. berghei in Anopheles stephensi.","method":"Gene knockout in P. berghei; quantification of gametocytes, oocysts, ookinetes, sporozoites; hepatocyte invasion assay; enzyme inhibition assays with C-532 and C-533; mosquito transmission assays","journal":"Emerging microbes & infections","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with multiple defined cellular phenotypes across life-cycle stages, complemented by pharmacological inhibition in two Plasmodium species","pmids":["35264080"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"finding":"MCA2 co-localizes with the Kelch13 (K13) compartment in P. falciparum asexual blood stages, placing it among the K13 compartment proteins associated with endocytic uptake of host cell cytosol and artemisinin susceptibility.","method":"BioID proximity labeling followed by fluorescence co-localization analysis; AlphaFold2 structural predictions for domain analysis","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization established by BioID and co-localization imaging, single lab, no functional consequence of MCA2's K13 compartment residence directly tested","pmids":["38039338"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2024,"finding":"Tunicamycin-induced ER stress in P. berghei upregulates MCA2 (PbMCA2) transcript levels, while 5-fluorouracil and chloroquine also upregulate PbMCA2, indicating transcriptional induction of MCA2 in response to drug-induced stress as part of an apoptosis-like pathway response.","method":"ex vivo P. berghei cultures treated with tunicamycin, 5-fluorouracil, and chloroquine; quantitative transcriptional analysis of PbMCA2 and autophagy markers","journal":"Parasitology research","confidence":"Low","confidence_rationale":"Tier 4 / Weak — transcriptional measurement only, no protein-level or functional mechanistic data for MCA2 itself","pmids":["38976068"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]}],"current_model":"MCA2 (PF3D7_1438400) is a cysteine protease with a Cys157-His205 catalytic dyad that cleaves Arg/Lys-specific substrates and proteolytically processes the natural substrate PfTSN via a non-canonical interaction requiring Tyr224 and Cys157; it localizes to the Kelch13 compartment in asexual blood stages, is expressed in schizonts and gametocytes, and is required for gametocyte formation, sporogony (oocysts, ookinetes, sporozoites), and hepatocyte invasion in P. berghei, with its inhibition causing oxidative stress, mitochondrial depolarization, and apoptosis-like parasite death."},"narrative":{"mechanistic_narrative":"MCA2 (PF3D7_1438400) is a Plasmodium cysteine protease that functions in stage-specific development and stress-linked, apoptosis-like death programs across the parasite life cycle [PMID:29317266, PMID:35264080]. Enzymatically it behaves as an arginine/lysine-specific protease rather than a canonical caspase: it cleaves z-GRR-AMC but not caspase substrates, and is blocked by Z-FA-FMK but not by general caspase inhibitors [PMID:29317266]. Catalysis depends on a Cys157-His205 dyad, while recognition and cleavage of its natural substrate, Tudor staphylococcal nuclease (PfTSN), requires both Cys157 and the non-conserved Tyr224, defining a non-canonical substrate-binding mode distinct from the residues needed for peptide-substrate turnover [PMID:29317266, PMID:35670460]. MCA2 is expressed in schizonts and gametocytes [PMID:29317266] and localizes to the Kelch13 compartment in asexual blood stages [PMID:38039338]. Genetic knockout in P. berghei establishes that MCA2 is required for gametocyte formation, for maintaining oocyst, ookinete, and sporozoite numbers, and for timely hepatocyte invasion [PMID:35264080]. Pharmacological inhibition by selective small molecules blocks parasite growth and mosquito transmission and triggers oxidative stress, mitochondrial depolarization, Ca2+ accumulation, phosphatidylserine externalization, and DNA fragmentation, marking an apoptosis-like death phenotype [PMID:29317266, PMID:32202613, PMID:35264080]. Beyond these findings, the direct functional consequence of MCA2's Kelch13-compartment residence and the downstream signaling of PfTSN cleavage have not been characterized in the available corpus.","teleology":[{"year":2018,"claim":"Established whether MCA2 is a true caspase or a distinct protease, resolving its enzymatic identity and defining a natural substrate.","evidence":"Fluorogenic peptide assays, inhibitor profiling, and in vitro cleavage of PfTSN in P. falciparum","pmids":["29317266"],"confidence":"Medium","gaps":["Structural basis of Arg/Lys specificity not resolved","Physiological role of PfTSN cleavage not defined","Single-lab in vitro characterization"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Linked MCA2 expression to specific life-cycle stages and connected its activity to an apoptosis-like death phenotype upon inhibition.","evidence":"Stage-specific Western blot, Z-FA-FMK growth inhibition, and apoptosis-marker flow cytometry in P. falciparum","pmids":["29317266"],"confidence":"Medium","gaps":["Z-FA-FMK is not MCA2-selective, so death phenotype attribution is indirect","Molecular effectors of the death program not identified"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"claim":"Determined that selective chemical inhibition of MCA2 alone drives an oxidative, mitochondrial, and Ca2+ death cascade, sharpening causal attribution to the enzyme.","evidence":"SS-5 inhibitor with a specificity panel, ROS/mitochondrial/Ca2+ assays in P. falciparum, and in vivo P. berghei model","pmids":["32202613"],"confidence":"Medium","gaps":["Order of ROS, mitochondrial, and Ca2+ events not established","Direct in-parasite target engagement of SS-5 not shown","Single lab"],"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium berghei","strain":""}]},{"year":2021,"claim":"Mapped the catalytic and substrate-recognition residues, showing that PfTSN engagement uses a non-canonical mode distinct from peptide-substrate catalysis.","evidence":"Site-directed mutagenesis of Cys157/His205/Tyr224 with in vitro and in vivo PfTSN cleavage assays in P. falciparum","pmids":["35670460"],"confidence":"Medium","gaps":["No structure of the MCA2-PfTSN complex","Broader substrate repertoire beyond PfTSN unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2022,"claim":"Defined the genetic requirement for MCA2 across the life cycle, establishing roles in gametocytogenesis, mosquito-stage development, and hepatocyte invasion, and its value as a transmission-blocking target.","evidence":"P. berghei gene knockout with life-cycle-stage quantification, plus C-532/C-533 inhibition and mosquito transmission assays in P. falciparum and P. berghei","pmids":["35264080"],"confidence":"High","gaps":["Molecular substrates driving each developmental defect not identified","Mechanistic basis of delayed hepatocyte invasion unknown"],"attribution":[{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"claim":"Placed MCA2 spatially within the Kelch13 compartment, associating it with host-cytosol endocytosis and artemisinin-relevant biology in asexual stages.","evidence":"BioID proximity labeling, co-localization imaging, and AlphaFold2 domain analysis in P. falciparum","pmids":["38039338"],"confidence":"Medium","gaps":["Functional consequence of K13-compartment residence not tested","Whether MCA2 contributes to artemisinin susceptibility unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2024,"claim":"Connected MCA2 to a stress-responsive transcriptional program, showing its induction under ER stress and drug pressure.","evidence":"Transcriptional analysis of PbMCA2 after tunicamycin, 5-fluorouracil, and chloroquine treatment in ex vivo P. berghei","pmids":["38976068"],"confidence":"Low","gaps":["Transcript-only, no protein or functional confirmation for MCA2","Causal link between induction and the death program not established"],"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":null,"claim":"How MCA2's protease activity and PfTSN cleavage mechanistically drive gametocytogenesis, mosquito-stage development, and the oxidative apoptosis-like cascade remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of MCA2 or its substrate complex","Full in vivo substrate repertoire unknown","Functional role of K13-compartment localization untested"],"attribution":[]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["Kelch13 (K13) compartment"],"partners":["PFTSN (TUDOR STAPHYLOCOCCAL NUCLEASE) — NATURAL SUBSTRATE"],"other_free_text":["Arg/Lys-specific cysteine protease that does not cleave canonical caspase substrates and is insensitive to general caspase inhibitors [#0].","Catalytic dyad Cys157-His205 required for activity; Tyr224 and Cys157 required for non-canonical PfTSN recognition [#2].","Expressed in schizonts and gametocytes [#1]; required in P. berghei for gametocyte formation, oocyst/ookinete/sporozoite numbers, and hepatocyte invasion [#4].","Selective inhibitors (SS-5, C-532, C-533) block growth and mosquito transmission and trigger oxidative stress, mitochondrial depolarization, and Ca2+ accumulation [#3, #4]."]}},"prefetch_data":{},"corpus_meta":[{"pmid":"38039338","id":"PMC_38039338","title":"The Kelch13 compartment contains highly divergent vesicle trafficking proteins in malaria parasites.","date":"2023","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/38039338","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MCA2"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29317266","id":"PMC_29317266","title":"Biochemical characterization of unusual cysteine protease of P. falciparum, metacaspase-2 (MCA-2).","date":"2018","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/29317266","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MCA2","metacaspase-2","PfMCA2"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"35264080","id":"PMC_35264080","title":"Dissecting The role of Plasmodium metacaspase-2 in malaria gametogenesis and sporogony.","date":"2022","source":"Emerging microbes & infections","url":"https://pubmed.ncbi.nlm.nih.gov/35264080","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MCA2","metacaspase-2"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32202613","id":"PMC_32202613","title":"A nonpeptidyl molecule modulates apoptosis-like cell death by inhibiting P. falciparum metacaspase-2.","date":"2020","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32202613","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["metacaspase-2","PfMCA2"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"35670460","id":"PMC_35670460","title":"Plasmodium falciparum metacaspase-2 capture its natural substrate in a non-canonical way.","date":"2021","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35670460","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MCA2","metacaspase-2","PfMCA2"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38976068","id":"PMC_38976068","title":"Drug-induced ER stress leads to induction of programmed cell death pathways of the malaria parasite.","date":"2024","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/38976068","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PbMCA2"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6016,"output_tokens":2351,"usd":0.026656,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7678,"output_tokens":3257,"usd":0.059908,"stage2_stop_reason":"end_turn"},"total_usd":0.086564,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"MCA2 (PfMCA-2) is a cysteine protease that cleaves arginine/lysine-specific peptide substrates (z-GRR-AMC) but not caspase-specific substrates (Z-VAD-FMK, Z-DEVD-FMK substrates), and is inhibited by Z-FA-FMK but not general caspase inhibitors. MCA2 also cleaves the phylogenetically conserved protein Tudor staphylococcal nuclease (PfTSN) as a natural substrate.\",\n      \"method\": \"Enzymatic assay with fluorogenic peptide substrates; inhibitor profiling with Z-FA-FMK, aprotinin, E-64, Z-VAD-FMK, Z-DEVD-FMK; in vitro cleavage assay with PfTSN\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro enzymatic assay with substrate specificity profiling and inhibitor panel, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"29317266\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MCA2 (PfMCA-2) is specifically expressed in schizont and gametocyte stages of P. falciparum. Treatment with Z-FA-FMK caused notable depletion of MCA2 expression in these stages and blocked parasite growth (IC50 2.7 µM), accompanied by phosphatidylserine externalization and DNA fragmentation indicative of apoptosis-like death.\",\n      \"method\": \"Western blot for stage-specific expression; drug treatment with Z-FA-FMK; parasite growth inhibition assay; flow cytometry for phosphatidylserine externalization and DNA fragmentation\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal readouts (expression, growth, apoptosis markers), single lab\",\n      \"pmids\": [\"29317266\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Active-site mutagenesis of MCA2 (PfMCA-2) established that the catalytic dyad residues Cys157 and His205 are essential for enzymatic activity with the artificial substrate z-GRR-AMC. The residue Tyr224 is not required for activity with the artificial substrate but is required for binding and cleavage of the natural substrate PfTSN; Cys157 is also required for PfTSN interaction, indicating MCA2 cleaves PfTSN via a non-canonical binding mode using non-conserved residues.\",\n      \"method\": \"Site-directed mutagenesis of Cys157, His205, and Tyr224; in vitro and in vivo PfTSN cleavage assays; enzymatic assay with z-GRR-AMC\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — active-site mutagenesis combined with in vitro and in vivo substrate cleavage assays, single lab\",\n      \"pmids\": [\"35670460\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A specific small-molecule inhibitor (SS-5) inhibited MCA2 (PfMCA-2) activity and expression without inhibiting falcipains, plasmepsins, vivapain, human cathepsins B/D/L, or caspases-3/7, demonstrating selectivity. Inhibition of MCA2 by SS-5 led to persistent oxidative stress, mitochondrial potential depolarization, and intracellular Ca2+ accumulation, causing apoptosis-like parasite death in vitro (IC50 1 µM). SS-5 also inhibited P. berghei development in a murine model.\",\n      \"method\": \"Enzyme activity assays with selectivity panel; parasite growth inhibition (IC50); ROS measurement; mitochondrial membrane potential assay; Ca2+ accumulation assay; murine P. berghei in vivo model\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional assays with selective inhibitor, replicated in two Plasmodium species, single lab\",\n      \"pmids\": [\"32202613\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium berghei\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Genetic knockout of MCA2 in P. berghei demonstrated that MCA2 is required for normal gametocyte formation, and for maintaining appropriate numbers of oocysts, ookinetes, and sporozoites; MCA2 knockout parasites also showed delayed hepatocyte invasion. Inhibitors C-532 and C-533 inhibited MCA2 activity, blocked in vitro parasite growth, and impaired transmission of P. falciparum and P. berghei in Anopheles stephensi.\",\n      \"method\": \"Gene knockout in P. berghei; quantification of gametocytes, oocysts, ookinetes, sporozoites; hepatocyte invasion assay; enzyme inhibition assays with C-532 and C-533; mosquito transmission assays\",\n      \"journal\": \"Emerging microbes & infections\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with multiple defined cellular phenotypes across life-cycle stages, complemented by pharmacological inhibition in two Plasmodium species\",\n      \"pmids\": [\"35264080\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium berghei\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MCA2 co-localizes with the Kelch13 (K13) compartment in P. falciparum asexual blood stages, placing it among the K13 compartment proteins associated with endocytic uptake of host cell cytosol and artemisinin susceptibility.\",\n      \"method\": \"BioID proximity labeling followed by fluorescence co-localization analysis; AlphaFold2 structural predictions for domain analysis\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization established by BioID and co-localization imaging, single lab, no functional consequence of MCA2's K13 compartment residence directly tested\",\n      \"pmids\": [\"38039338\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Tunicamycin-induced ER stress in P. berghei upregulates MCA2 (PbMCA2) transcript levels, while 5-fluorouracil and chloroquine also upregulate PbMCA2, indicating transcriptional induction of MCA2 in response to drug-induced stress as part of an apoptosis-like pathway response.\",\n      \"method\": \"ex vivo P. berghei cultures treated with tunicamycin, 5-fluorouracil, and chloroquine; quantitative transcriptional analysis of PbMCA2 and autophagy markers\",\n      \"journal\": \"Parasitology research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — transcriptional measurement only, no protein-level or functional mechanistic data for MCA2 itself\",\n      \"pmids\": [\"38976068\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"MCA2 (PF3D7_1438400) is a cysteine protease with a Cys157-His205 catalytic dyad that cleaves Arg/Lys-specific substrates and proteolytically processes the natural substrate PfTSN via a non-canonical interaction requiring Tyr224 and Cys157; it localizes to the Kelch13 compartment in asexual blood stages, is expressed in schizonts and gametocytes, and is required for gametocyte formation, sporogony (oocysts, ookinetes, sporozoites), and hepatocyte invasion in P. berghei, with its inhibition causing oxidative stress, mitochondrial depolarization, and apoptosis-like parasite death.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MCA2 (PF3D7_1438400) is a Plasmodium cysteine protease that functions in stage-specific development and stress-linked, apoptosis-like death programs across the parasite life cycle [#0, #4]. Enzymatically it behaves as an arginine/lysine-specific protease rather than a canonical caspase: it cleaves z-GRR-AMC but not caspase substrates, and is blocked by Z-FA-FMK but not by general caspase inhibitors [#0]. Catalysis depends on a Cys157-His205 dyad, while recognition and cleavage of its natural substrate, Tudor staphylococcal nuclease (PfTSN), requires both Cys157 and the non-conserved Tyr224, defining a non-canonical substrate-binding mode distinct from the residues needed for peptide-substrate turnover [#0, #2]. MCA2 is expressed in schizonts and gametocytes [#1] and localizes to the Kelch13 compartment in asexual blood stages [#5]. Genetic knockout in P. berghei establishes that MCA2 is required for gametocyte formation, for maintaining oocyst, ookinete, and sporozoite numbers, and for timely hepatocyte invasion [#4]. Pharmacological inhibition by selective small molecules blocks parasite growth and mosquito transmission and triggers oxidative stress, mitochondrial depolarization, Ca2+ accumulation, phosphatidylserine externalization, and DNA fragmentation, marking an apoptosis-like death phenotype [#1, #3, #4]. Beyond these findings, the direct functional consequence of MCA2's Kelch13-compartment residence and the downstream signaling of PfTSN cleavage have not been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2018,\n      \"claim\": \"Established whether MCA2 is a true caspase or a distinct protease, resolving its enzymatic identity and defining a natural substrate.\",\n      \"evidence\": \"Fluorogenic peptide assays, inhibitor profiling, and in vitro cleavage of PfTSN in P. falciparum\",\n      \"pmids\": [\"29317266\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of Arg/Lys specificity not resolved\", \"Physiological role of PfTSN cleavage not defined\", \"Single-lab in vitro characterization\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked MCA2 expression to specific life-cycle stages and connected its activity to an apoptosis-like death phenotype upon inhibition.\",\n      \"evidence\": \"Stage-specific Western blot, Z-FA-FMK growth inhibition, and apoptosis-marker flow cytometry in P. falciparum\",\n      \"pmids\": [\"29317266\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Z-FA-FMK is not MCA2-selective, so death phenotype attribution is indirect\", \"Molecular effectors of the death program not identified\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Determined that selective chemical inhibition of MCA2 alone drives an oxidative, mitochondrial, and Ca2+ death cascade, sharpening causal attribution to the enzyme.\",\n      \"evidence\": \"SS-5 inhibitor with a specificity panel, ROS/mitochondrial/Ca2+ assays in P. falciparum, and in vivo P. berghei model\",\n      \"pmids\": [\"32202613\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Order of ROS, mitochondrial, and Ca2+ events not established\", \"Direct in-parasite target engagement of SS-5 not shown\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}, {\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapped the catalytic and substrate-recognition residues, showing that PfTSN engagement uses a non-canonical mode distinct from peptide-substrate catalysis.\",\n      \"evidence\": \"Site-directed mutagenesis of Cys157/His205/Tyr224 with in vitro and in vivo PfTSN cleavage assays in P. falciparum\",\n      \"pmids\": [\"35670460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the MCA2-PfTSN complex\", \"Broader substrate repertoire beyond PfTSN unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined the genetic requirement for MCA2 across the life cycle, establishing roles in gametocytogenesis, mosquito-stage development, and hepatocyte invasion, and its value as a transmission-blocking target.\",\n      \"evidence\": \"P. berghei gene knockout with life-cycle-stage quantification, plus C-532/C-533 inhibition and mosquito transmission assays in P. falciparum and P. berghei\",\n      \"pmids\": [\"35264080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular substrates driving each developmental defect not identified\", \"Mechanistic basis of delayed hepatocyte invasion unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placed MCA2 spatially within the Kelch13 compartment, associating it with host-cytosol endocytosis and artemisinin-relevant biology in asexual stages.\",\n      \"evidence\": \"BioID proximity labeling, co-localization imaging, and AlphaFold2 domain analysis in P. falciparum\",\n      \"pmids\": [\"38039338\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of K13-compartment residence not tested\", \"Whether MCA2 contributes to artemisinin susceptibility unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected MCA2 to a stress-responsive transcriptional program, showing its induction under ER stress and drug pressure.\",\n      \"evidence\": \"Transcriptional analysis of PbMCA2 after tunicamycin, 5-fluorouracil, and chloroquine treatment in ex vivo P. berghei\",\n      \"pmids\": [\"38976068\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Transcript-only, no protein or functional confirmation for MCA2\", \"Causal link between induction and the death program not established\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MCA2's protease activity and PfTSN cleavage mechanistically drive gametocytogenesis, mosquito-stage development, and the oxidative apoptosis-like cascade remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of MCA2 or its substrate complex\", \"Full in vivo substrate repertoire unknown\", \"Functional role of K13-compartment localization untested\"],\n      \"attribution\": []\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004197\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0008234\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0006508\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020005\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0097194\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0034976\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0006915\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"complexes\": [\n      \"Kelch13 (K13) compartment\"\n    ],\n    \"partners\": [\n      \"PfTSN (Tudor staphylococcal nuclease) — natural substrate\"\n    ],\n    \"other_free_text\": [\n      \"Arg/Lys-specific cysteine protease that does not cleave canonical caspase substrates and is insensitive to general caspase inhibitors [#0].\",\n      \"Catalytic dyad Cys157-His205 required for activity; Tyr224 and Cys157 required for non-canonical PfTSN recognition [#2].\",\n      \"Expressed in schizonts and gametocytes [#1]; required in P. berghei for gametocyte formation, oocyst/ookinete/sporozoite numbers, and hepatocyte invasion [#4].\",\n      \"Selective inhibitors (SS-5, C-532, C-533) block growth and mosquito transmission and trigger oxidative stress, mitochondrial depolarization, and Ca2+ accumulation [#3, #4].\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1438400","name":null,"product":"metacaspase-2","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1302300","name":null,"product":"metacaspase-2, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_1244000","name":null,"product":"metacaspase-2, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"MCA2","evaluation":null}